Clinical Trials on Paraproteinemias in New Zealand
Total 852 results
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingIdasanutlin, Ixazomib Citrate, and Dexamethasone in Treating Patients With Relapsed Multiple MyelomaRecurrent Plasma Cell Myeloma | Loss of Chromosome 17pUnited States
-
CelgeneActive, not recruitingMultiple MyelomaUnited States, France, Spain, Germany, Greece
-
Southwest Oncology GroupNational Cancer Institute (NCI)TerminatedMultiple MyelomaUnited States
-
Accelerated Community Oncology Research NetworkMillennium Pharmaceuticals, Inc.TerminatedMultiple MyelomaUnited States
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI); European Organisation for Research and Treatment... and other collaboratorsCompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States, Canada
-
OncotherapeuticsWithdrawnStage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Plasma Cell NeoplasmUnited States
-
SanofiCompletedPlasma Cell MyelomaUnited States
-
Janssen Research & Development, LLCCompletedMultiple MyelomaUnited States, France, Spain
-
CelgeneCompletedMultiple MyelomaUnited States, Japan
-
CephalonTerminated
-
Prothena Biosciences Ltd.CompletedAL AmyloidosisUnited States, Spain, Australia, Germany, United Kingdom, France, Greece, Israel, Italy, Austria
-
CelgeneActive, not recruitingMultiple MyelomaUnited States, Italy, Canada, France, Germany, Netherlands, Spain
-
CelgeneActive, not recruitingMultiple MyelomaFrance, United States, Canada, Spain, Italy
-
AbbVieGenentech, Inc.; Celgene CorporationWithdrawnMultiple MyelomaUnited States, Australia, Canada, Spain
-
Oncopeptides ABApproved for marketingRelapsed and/or Refractory Multiple MyelomaUnited States
-
Hoffmann-La RocheCompleted
-
Fate TherapeuticsTerminatedAcute Myeloid Leukemia | Multiple Myeloma | Myeloma | AML, AdultUnited States
-
Poseida Therapeutics, Inc.Roche-GenentechRecruitingMultiple MyelomaUnited States
-
Pharmacyclics LLC.CompletedMultiple MyelomaUnited States, Canada
-
Pharmacyclics LLC.Celgene CorporationTerminatedMultiple MyelomaUnited States, Spain, Australia, Czechia, Germany, Greece
-
Gilead SciencesCompletedLymphoma, Follicular | Lymphoma, B-Cell | Lymphoma, Non-Hodgkin | Lymphoma, Low-Grade | Lymphoma, Small Lymphocytic | Leukemia, Prolymphocytic | NHL | CLL | Leukemia, Lymphocytic, Chronic | Lymphoma, Intermediate-Grade | Lymphoma, Large-Cell | Lymphoma, Mixed-Cell | Lymphoma, Small-Cell | Leukemia, B-Cell, Chronic | Leukemia... and other conditionsUnited States
-
Cedars-Sinai Medical CenterEnrolling by invitationAmyloidosis, Immunoglobulin Light-chainUnited States, Canada
-
Multiple Myeloma Research FoundationSpectrum Health Hospitals; Translational Genomics Research Institute; Van Andel...CompletedMultiple MyelomaUnited States, Spain, Canada
-
Millennium Pharmaceuticals, Inc.Completed
-
Janssen Research & Development, LLCActive, not recruiting
-
National Cancer Institute (NCI)CompletedDexamethasone With or Without Thalidomide in Treating Patients With Newly Diagnosed Multiple MyelomaMultiple Myeloma and Plasma Cell NeoplasmUnited States, Puerto Rico, South Africa
-
Prelude TherapeuticsCompletedAcute Myeloid Leukemia | Myelodysplastic Syndromes | Multiple Myeloma | Non Hodgkin LymphomaUnited States
-
Alexion PharmaceuticalsTerminatedMultiple Myeloma | B-cell Chronic Lymphocytic LeukemiaUnited States
-
Janssen Research & Development, LLCRecruitingHematological MalignanciesUnited States, Netherlands, Spain, France, Sweden
-
Janssen Research & Development, LLCCompleted
-
Millennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited Kingdom, Spain, Canada, United States, Czechia
-
SanofiCompletedPlasma Cell MyelomaFrance, Spain, Greece, Korea, Republic of, United States, Australia, Belgium, Canada, Czechia, Denmark, Germany, Hungary, Italy, Japan, New Zealand, Norway, Poland, Portugal, Russian Federation, Slovakia, Sweden, Taiwan, Turkey, United...
-
Genentech, Inc.RecruitingMultiple MyelomaUnited States, Canada, Spain, Australia
-
Bristol-Myers SquibbAbbVieCompleted
-
Eisai Inc.Helsinn Healthcare SACompleted
-
PfizerCompletedNeoplasms | Multiple Myeloma | Lymphoma, Malignant | ThrombocytopeniaUnited States, Argentina, Mexico
-
TeneoOne Inc.RecruitingRelapsed/Refractory Multiple MyelomaAustralia, Germany, Japan, Spain, United States, Italy, Poland
-
Millennium Pharmaceuticals, Inc.CompletedMultiple Myeloma | Advanced Solid TumorsUnited States, Canada
-
AmgenTerminatedRelapsed/Refractory Multiple MyelomaUnited States, Australia, Japan, Germany, Netherlands, Canada
-
Fate TherapeuticsRecruiting
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | Leukemia | Small Intestine Cancer | Prostate Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
GlaxoSmithKlineActive, not recruitingMultiple MyelomaAustralia, Japan, Spain, Germany, Poland, Belgium, Israel, Italy, Russian Federation, Canada, New Zealand, Korea, Republic of, China, Brazil, Czechia, United States, Netherlands, United Kingdom, Greece, France
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaCanada, United States, Germany, Netherlands, Spain
-
SanofiCompletedMultiple MyelomaFrance, Spain, Belgium, Australia, United States, Japan
-
Gilead SciencesCompletedMultiple MyelomaUnited States, Czechia, Canada
-
CelgeneCompletedMultiple MyelomaUnited States, Spain, Austria, Greece, Netherlands, Sweden
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaUnited States, Netherlands, Belgium, Korea, Republic of, United Kingdom, Sweden, Denmark, Italy, Japan, Germany, France, Spain, Australia, Israel, Poland, Greece
-
UNC Lineberger Comprehensive Cancer CenterBoston University; The Leukemia and Lymphoma SocietyRecruitingMultiple Myeloma | Chronic Lymphocytic LeukemiaUnited States
-
PfizerRecruiting
-
Janssen Research & Development, LLCRecruitingHematological MalignanciesUnited States, Netherlands, Spain, Belgium